Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charlotte E Costentin

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
JHEP Reports : Innovation in Hepatology|July 26, 2021
HCC risk prediction using biomarkers in non-cirrhotic patients following HCV eradication: Reassuring the patient or the doctor?Charlotte E Costentin, Pierre Nahon
JAMA Oncology|March 16, 2018
Hepatocellular Carcinoma With Portal Venous Invasion: Radiating New Hope?Khashayar Farsad, Charlotte E Costentin, Andrew X Zhu
Journal of Hepatology|May 3, 2018
Reply to: "Response to: Positron emission tomography/computed tomography with <sup>18</sup>F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma"Julia Chalaye, Charlotte E Costentin, Alain Luciani, et al.
Expert Review of Anti-Infective Therapy|June 3, 2009
Treatment of HBV-related cirrhosisAnais Vallet-Pichard, Vincent Mallet, Charlotte E Costentin, et al.
Hepatology (Baltimore, Md.)|September 20, 2018
Is It Time to Reconsider the Milan Criteria for Selecting Patients With Hepatocellular Carcinoma for Deceased-Donor Liver Transplantation?Charlotte E Costentin, Yanik J Bababekov, Andrew X Zhu, et al.
Gastroenterology|November 26, 2018
ReplyCharlotte E Costentin, Richard Layese, Françoise Roudot-Thoraval, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 24, 2022
Alcohol-related hepatocellular carcinoma is a heterogenous condition: Lessons from a latent class analysisCharlotte E Costentin, Mélanie Minoves, Sylvain Kotzki, et al.
Digestive Diseases and Sciences|July 27, 2019
Geographical Disparities of Outcomes of Hepatocellular Carcinoma in France: The Heavier Burden of Alcohol Compared to Hepatitis CCharlotte E Costentin, Philippe Sogni, Bruno Falissard, et al.
Liver Cancer|December 14, 2017
Hepatocellular Carcinoma with Macrovascular Invasion: Defining the Optimal Treatment StrategyCharlotte E Costentin, Cristina R Ferrone, Ronald S Arellano, et al.
Journal of Hepatology|December 15, 2010
Association of caffeine intake and histological features of chronic hepatitis CCharlotte E Costentin, Françoise Roudot-Thoraval, Elie-Serge Zafrani, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
JHEP Reports : Innovation in Hepatology|July 26, 2021
HCC risk prediction using biomarkers in non-cirrhotic patients following HCV eradication: Reassuring the patient or the doctor?Charlotte E Costentin, Pierre Nahon
JAMA Oncology|March 16, 2018
Hepatocellular Carcinoma With Portal Venous Invasion: Radiating New Hope?Khashayar Farsad, Charlotte E Costentin, Andrew X Zhu
Journal of Hepatology|May 3, 2018
Reply to: "Response to: Positron emission tomography/computed tomography with <sup>18</sup>F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma"Julia Chalaye, Charlotte E Costentin, Alain Luciani, et al.
Expert Review of Anti-Infective Therapy|June 3, 2009
Treatment of HBV-related cirrhosisAnais Vallet-Pichard, Vincent Mallet, Charlotte E Costentin, et al.
Hepatology (Baltimore, Md.)|September 20, 2018
Is It Time to Reconsider the Milan Criteria for Selecting Patients With Hepatocellular Carcinoma for Deceased-Donor Liver Transplantation?Charlotte E Costentin, Yanik J Bababekov, Andrew X Zhu, et al.
Gastroenterology|November 26, 2018
ReplyCharlotte E Costentin, Richard Layese, Françoise Roudot-Thoraval, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 24, 2022
Alcohol-related hepatocellular carcinoma is a heterogenous condition: Lessons from a latent class analysisCharlotte E Costentin, Mélanie Minoves, Sylvain Kotzki, et al.
Digestive Diseases and Sciences|July 27, 2019
Geographical Disparities of Outcomes of Hepatocellular Carcinoma in France: The Heavier Burden of Alcohol Compared to Hepatitis CCharlotte E Costentin, Philippe Sogni, Bruno Falissard, et al.
Liver Cancer|December 14, 2017
Hepatocellular Carcinoma with Macrovascular Invasion: Defining the Optimal Treatment StrategyCharlotte E Costentin, Cristina R Ferrone, Ronald S Arellano, et al.
Journal of Hepatology|December 15, 2010
Association of caffeine intake and histological features of chronic hepatitis CCharlotte E Costentin, Françoise Roudot-Thoraval, Elie-Serge Zafrani, et al.
Pageof 3